Mirvetuximab MMAE Antibody
Mirvetuximab soravtansine is an anti-FOLR1 antibody-drug conjugate (ADC) produced in CHO cells, featuring a human IgG1/kappa structure. It is utilized in preclinical research for targeting folate receptor alpha-positive cancers, with studies demonstrating its activity in both in vitro cytotoxicity assays and in vivo xenograft models.
Product Specifications
Target
Antifolate
Conjugation
Unconjugated
Field of Research
Cell Biology
Molecular Weight
145 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940994-100 1x 100 µL
TNF alpha (J2D10), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680096-100 1x 100 µL
Histone H1 (AE-4), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682059-100 1x 100 µL
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401830-500 1x 500 µL
CD68 (Macrophage Marker) (LAMP4/1830), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402659-100 1x 100 µL
Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker) (KRT13/2213), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details